Literature DB >> 24759141

Physiologic activities of the contact activation system.

Alvin H Schmaier1.   

Abstract

The plasma contact activation (CAS) and kallikrein/kinin (KKS) systems consist of 4 proteins: factor XII, prekallikrein, high molecular weight kininogen, and the bradykinin B2 receptor. Murine genetic deletion of factor XII (F12(-/-)), prekallikrein (Klkb1(-/-)), high molecular weight kininogen (Kgn1(-/-)) and the bradykinin B2 receptor (Bdkrb2(-/-)) yield animals protected from thrombosis. With possible exception of F12(-/-) and Kgn1(-/-) mice, the mechanism(s) for thrombosis protection is not reduced contact activation. Bdkrb2(-/-) mice are best characterized and they are protected from thrombosis through over expression of components of the renin angiotensin system (RAS) leading to elevated prostacyclin with vascular and platelet inhibition. Alternatively, prolylcarboxypeptidase, a PK activator and degrader of angiotensin II, when deficient in the mouse leads to a prothrombotic state. Its mechanism for increased thrombosis also is mediated in part by components of the RAS. These observations suggest that thrombosis in mice of the CAS and KKS are mediated in part through the RAS and independent of reduced contact activation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiotensin receptor 2; Bradykinin B2 receptor; Contact activation; Factor XII; High molecular weight kininogen; Kallikrein/kinin system; Mas receptor; Prekallikrein; Prolycarboxypeptidase; Renin angiotensin system

Mesh:

Substances:

Year:  2014        PMID: 24759141      PMCID: PMC4004333          DOI: 10.1016/j.thromres.2014.03.018

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  30 in total

Review 1.  The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction.

Authors:  Alvin H Schmaier
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-07       Impact factor: 3.619

2.  Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney.

Authors:  C E Odya; D V Marinkovic; K J Hammon; T A Stewart; E G Erdös
Journal:  J Biol Chem       Date:  1978-09-10       Impact factor: 5.157

3.  The expression of high molecular weight kininogen on human umbilical vein endothelial cells.

Authors:  A H Schmaier; A Kuo; D Lundberg; S Murray; D B Cines
Journal:  J Biol Chem       Date:  1988-11-05       Impact factor: 5.157

4.  Human neutrophils contain and bind high molecular weight kininogen.

Authors:  E J Gustafson; A H Schmaier; Y T Wachtfogel; N Kaufman; U Kucich; R W Colman
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

5.  High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation.

Authors:  G Motta; R Rojkjaer; A A Hasan; D B Cines; A H Schmaier
Journal:  Blood       Date:  1998-01-15       Impact factor: 22.113

6.  Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells.

Authors:  A A Hasan; T Zisman; A H Schmaier
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

7.  The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells.

Authors:  Fakhri Mahdi; Zia Shariat-Madar; Alvin H Schmaier
Journal:  J Biol Chem       Date:  2003-08-27       Impact factor: 5.157

8.  Recombinant prolylcarboxypeptidase activates plasma prekallikrein.

Authors:  Zia Shariat-Madar; Fakhri Mahdi; Alvin H Schmaier
Journal:  Blood       Date:  2004-03-02       Impact factor: 22.113

9.  High-molecular weight kininogen. A secreted platelet protein.

Authors:  A H Schmaier; A Zuckerberg; C Silverman; J Kuchibhotla; G P Tuszynski; R W Colman
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

10.  High molecular weight kininogen binds to unstimulated platelets.

Authors:  E J Gustafson; D Schutsky; L C Knight; A H Schmaier
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

View more
  21 in total

Review 1.  The initiation and effects of plasma contact activation: an overview.

Authors:  Lisha Lin; Mingyi Wu; Jinhua Zhao
Journal:  Int J Hematol       Date:  2016-11-15       Impact factor: 2.490

Review 2.  Factor XI and contact activation as targets for antithrombotic therapy.

Authors:  D Gailani; C E Bane; A Gruber
Journal:  J Thromb Haemost       Date:  2015-06-16       Impact factor: 5.824

3.  Elevated extracellular trap formation and contact system activation in acute leukemia.

Authors:  Tae Yeul Kim; Ja-Yoon Gu; Hye Soo Jung; Youngil Koh; Inho Kim; Hyun Kyung Kim
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

4.  Role of the coagulation system in the pathogenesis of sickle cell disease.

Authors:  Md Nasimuzzaman; Punam Malik
Journal:  Blood Adv       Date:  2019-10-22

5.  Surface dependent contact activation of factor XII and blood plasma coagulation induced by mixed thiol surfaces.

Authors:  James W Bauer; Li-Chong Xu; Erwin A Vogler; Christopher A Siedlecki
Journal:  Biointerphases       Date:  2017-05-17       Impact factor: 2.456

6.  A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.

Authors:  Yasin Kokoye; Ivan Ivanov; Qiufang Cheng; Anton Matafonov; S Kent Dickeson; Shauna Mason; Daniel J Sexton; Thomas Renné; Keith McCrae; Edward P Feener; David Gailani
Journal:  Thromb Res       Date:  2016-02-18       Impact factor: 3.944

Review 7.  The hemostatic role of factor XI.

Authors:  Cristina Puy; Rachel A Rigg; Owen J T McCarty
Journal:  Thromb Res       Date:  2016-05       Impact factor: 3.944

8.  Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.

Authors:  Lakshmi C Wijeyewickrema; Emilie Lameignere; Lilian Hor; Renee C Duncan; Toshikazu Shiba; Richard J Travers; Piyushkumar R Kapopara; Victor Lei; Stephanie A Smith; Hugh Kim; James H Morrissey; Robert N Pike; Edward M Conway
Journal:  Blood       Date:  2016-06-23       Impact factor: 22.113

9.  Changes in coagulation factor XII and its function during aortic arch surgery for acute aortic dissection-a prospective observational study.

Authors:  Jiachen Li; Xinliang Guan; Ou Liu; Xiaolong Wang; Yuyong Liu; Haiyang Li; Feng Lan; Ming Gong; Hongjia Zhang
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

10.  Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS).

Authors:  Arina J ten Cate-Hoek; Jeffrey I Weitz; David Gailani; Karina Meijer; Helen Philippou; Annemieke C Bouman; Y Whitney Cheung; Thijs E van Mens; Jose W Govers-Riemslag; Minka Vries; Suzanne Bleker; Jossi S Biedermann; S Carina M Stoof; Harry R Buller
Journal:  Thromb Res       Date:  2015-09       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.